Study protocol for a phase II dose evaluation randomized controlled trial of cholecalciferol in critically ill children with vitamin D deficiency (VITdAL-PICU study)
Kusum Menon(University of Ottawa), Stephanie Redpath(University of Ottawa), Margaret L. Lawson(Children's Hospital of Eastern Ontario), Hope A. Weiler(Health Canada), Dean Fergusson(Ottawa Hospital), Karin Amrein(Medical University of Graz), Pavel Geier(University of Ottawa), Lauralyn McIntyre(Ottawa Hospital Research Institute), M. David Henderson(Newborn Screening Ontario), Ali Khamessan, Dayre McNally(University of Ottawa)
Cited by 33
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
|Cochrane Database of Systematic Reviews|2016|1.2k